Check out our infographic that highlights the health issues and respective clinical trial strategies associated with obesity, including Type 2 diabetes (T2D), hypertension, chronic kidney disease, metabolic dysfunction-associated steatohepatitis (MASH), and cardiovascular disease. We discuss the importance of an integrated approach to managing obesity and its comorbidities, noting that treatments aimed at weight loss can subsequently improve the control of T2D and cardiometabolic outcomes.
Read the infographic to learn more about:
- The exploration of combination therapies, such as GLP-1 agonists with other treatments, to address these conditions.
- Innovative program strategies for hypothesis generation, testing, and considering geographical heterogeneity.
- Current work conducted to evaluate the effects of treatments on key clinical outcomes, stratified by age, T2D status, obesity, and concomitant medications.
